- Investing Ideas
- /
- Global Fast Growing Stocks With High Insider Ownership
Global Fast Growing Stocks With High Insider Ownership
UPDATED Jun 27, 2024
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
1,451 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
KEBNI B | SEK 1.62 | -2.9% | 30.6% | SEK 439.8m | SEK 2.20 | PS4.8x | E90.4% | n/a | Tech | ||
CALTX | SEK 205.60 | 0.4% | 140.0% | SEK 11.0b | SEK 221.25 | PS8.4x | E52.9% | n/a | Pharmaceuticals & Biotech | ||
CRDO | US$31.29 | 10.3% | 78.3% | US$4.9b | US$29.42 | PS26.8x | E60.9% | n/a | Semiconductors | ||
A178320 | ₩28,100.00 | -0.7% | 43.6% | ₩1.6t | ₩36,666.67 | PE145.5x | E48.1% | 0% | Tech | ||
A179900 | ₩30,050.00 | 0.2% | 55.7% | ₩475.4b | ₩60,000.00 | PS23.7x | E122.7% | 0% | Tech | ||
A204620 | ₩3,590.00 | -7.4% | -8.4% | ₩203.9b | ₩7,100.00 | PS1.9x | E72.4% | n/a | Commercial Services | ||
PLT | AU$0.78 | -2.5% | 108.0% | AU$136.8m | AU$1.30 | PS1.9x | E106.4% | n/a | Diversified Financials | ||
EH | US$13.59 | -3.3% | -11.1% | US$863.2m | US$24.98 | PS39.8x | E74.3% | n/a | Capital Goods | ||
300181 | CN¥15.02 | -3.0% | 23.0% | CN¥10.5b | n/a | PE24.6x | E22.3% | 3.0% | Pharmaceuticals & Biotech | ||
A441270 | ₩9,070.00 | 3.1% | 2.1% | ₩335.3b | ₩11,500.00 | PE21.6x | E36.4% | n/a | Tech | ||
GIG | NOK 29.75 | 10.8% | 20.4% | NOK 4.0b | NOK 45.03 | PE19.2x | E36.9% | n/a | Consumer Services | ||
A067310 | ₩20,500.00 | -7.2% | -6.2% | ₩972.2b | ₩31,666.67 | PB3.3x | E94.1% | 0.2% | Semiconductors | ||
ACI | ₹669.00 | -4.0% | 24.8% | ₹81.1b | ₹757.20 | PE25.9x | E28.9% | 0.4% | Materials | ||
VOW | NOK 6.61 | 14.0% | -49.2% | NOK 752.5m | NOK 11.00 | PB1.9x | E97.6% | 0% | Commercial Services | ||
HHR | AU$0.006 | -14.3% | -76.9% | AU$16.9m | n/a | PE5.7x | E86.3% | n/a | Energy | ||
OSE | €5.86 | -1.3% | 77.6% | €127.5m | €7.15 | PS57.2x | E79.3% | n/a | Pharmaceuticals & Biotech | ||
688408 | CN¥92.08 | -9.7% | 9.2% | CN¥12.4b | CN¥89.23 | PE27x | E25.8% | 1.0% | Capital Goods | ||
4480 | JP¥3,600.00 | 0.1% | -32.6% | JP¥116.8b | JP¥5,800.00 | PE43.7x | E28.7% | n/a | Healthcare | ||
517522 | ₹589.60 | 0.3% | -29.4% | ₹29.9b | ₹772.00 | PE41.7x | E33.5% | 0.3% | Materials | ||
ADOC | €8.70 | 14.0% | 119.7% | €128.1m | €9.70 | PS21.2x | E104.5% | n/a | Pharmaceuticals & Biotech | ||
SDR | AU$5.09 | -0.8% | 74.3% | AU$1.4b | AU$6.46 | PS8.2x | E75.1% | n/a | Software | ||
CTT | AU$1.17 | -47.8% | -62.4% | AU$478.2m | AU$3.12 | PE23x | E26.7% | n/a | Retail | ||
ATAT | US$18.02 | -2.1% | 11.1% | US$2.5b | US$27.17 | PE18.5x | E21.7% | 0.8% | Consumer Services | ||
PHC | UK£0.086 | 45.0% | -5.2% | UK£29.5m | n/a | PS3.3x | E121.3% | n/a | Materials |